Encoding active antigen-specific immune tolerance using mRNA-LNPs for the treatment of autoimmune diseases
Time: 11:30 am
day: Seminar Day pt 2
Details:
• Discussion of the benefits gained by including an active immune modulator in antigen-specific tolerance approaches
• Considerations when using an mRNA-LNP approach for autoimmunity
• Pre-clinical data in models of autoimmune disease.
